Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Low-Dose Versus Standard-Dose Alteplase for Intravenous Thrombolysis in Patients With Acute Ischemic Stroke in Iran: Results From the Safe Implementation of Treatments in Stroke Registry Publisher



Sadeghihokmabadi E1 ; Ghoreishi A2 ; Rikhtegar R3 ; Sariaslani P4 ; Rafie S5 ; Vakilian A6, 7 ; Sharifipour E8 ; Mehrpour M9 ; Saadatnia M10 ; Mirzaaghazadehattari M11 ; Farhoudi M1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Neurosciences Research Center AND Division of Neurology, Imam Reza Hospital, Tabriz University of Medical Sciences, Tabriz, Iran
  2. 2. Stroke Research Group, Vali-e-Asr Hospital AND Department of Neurology and Stroke Unit, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran
  3. 3. Institute of Diagnostic and Interventional Radiology and Neuroradiology, School of Medicine, Essen University Hospital, Germany
  4. 4. Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
  5. 5. Department of Neurology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
  6. 6. Department of Neurology, School of Medicine, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
  7. 7. Non-Communicable Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
  8. 8. Neuroscience Research Center, Qom University of Medical Sciences, Qom, Iran
  9. 9. Iranian Stroke Association, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  10. 10. Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  11. 11. Medical Imaging Research Group, Tabriz University of Medical Sciences, Tabriz, Iran

Source: Current Journal of Neurology Published:2021


Abstract

Background: Rates of intracranial hemorrhage (ICH) after intravenous thrombolysis (IVT) differ depending on ethnicity, one reason that few Eastern countries have approved a lower dose of alteplase. Data in this regard are scarce in the Middle Eastern region. Methods: The present retrospective study was performed on data extracted from the Safe Implementation of Treatments in Stroke (SITS) registry. Computed tomography (CT) image analysis was based on the SITS-Monitoring Study (SITS-MOST) definition for symptomatic ICH (SICH). Functional outcome at 3 months was assessed using the modified Rankin Scale (mRS). Multivariate logistic regression including adjusted analysis was used for comparison between groups. Results: Of 6615 patients, 1055 were enrolled. A total of 86% (n = 906) received a standard dose and 14% (n = 149) received a low dose of alteplase. Favorable 3-month outcome was achieved in 481 (53%) patients in the standard group and 71 (48%) patients in the low-dose group [adjusted odds ratio (AOR) = 1.24, 95% confidence interval (CI): 0.87-1.75, P = 0.218]. SICH occurred in 14 (1.5%) patients in the standard group and 3 (2%) patients in the low-dose group [odds ratio (OR) = 2.77, 95% CI: 0.36-21.04, P = 0.120]. At 3 months, mortality occurred in 145 (16.0%) patients in the standard group and 29 (19.4%) patients in the low-dose group (OR = 1.22, 95% CI: 0.78-1.91, P = 0.346). Conclusion: Low-dose compared to standard-dose alteplase for patients with acute ischemic stroke (AIS) was not associated with fewer hemorrhagic events and there was no significant difference in the favorable 3-month outcome (mRS: 0-2) or mortality rate. © 2021 Iranian Neurological Association, and Tehran University of Medical Sciences.
Related Docs
View other Related Docs
1. Dose Optimization Study for Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke: A Study From Middle-East, Neurology Asia (2021)
2. Barthel Index in a Middle-East Country: Translation, Validity and Reliability, Cerebrovascular Diseases (2006)
3. Optimizing Acute Ischemic Stroke Outcomes: The Role of Tenecteplase Before Mechanical Thrombectomy, Clinical Therapeutics (2024)
4. Distribution by Location of Ct-Diagnosed Primary Intracerebral Hemorrhage in Isfahan, Journal of Research in Medical Sciences (2005)
5. Intracranial Hemorrhage in Normotensive and Hypertensive Patients Receiving Streptokinase After Decreasing Elevated Blood Pressure, Journal of Research in Medical Sciences (2005)
6. Neuroprotective Effects of Erythropoietin in Acute Ischemic Stroke, International Journal of Preventive Medicine (2013)
7. A Multicenter Diagnostic Accuracy Study on Prehospital Stroke Screening Scales, Archives of Iranian Medicine (2021)
8. The Frequency of Recurrence in Primary Hypertensive Intracerebral Hemorrhage, Journal of Research in Medical Sciences (2006)
Experts (# of related papers)
View all Related Experts
Mohammad Saadatnia (16)
Fariborz Khorvash (8)
Other Related Docs
9. Global, Regional, and National Burden of Stroke and Its Risk Factors, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019, The Lancet Neurology (2021)
10. Cerebral Vasospasm Following Traumatic Subarachnoid Hemorrhage, Journal of Research in Medical Sciences (2009)
11. Tissue Plasminogen Activator; Identifying Major Barriers Related to Intravenous Injection in Ischemic Acute Cerebral Infraction, Journal of Research in Medical Sciences (2017)
12. Re-Evaluating Risk Factors, Incidence, and Outcome of Aneurysmal and Non-Aneurysmal Subarachnoid Hemorrhage, World Neurosurgery (2023)
13. Evaluation of the Neuroprotective Effect of Dextromethorphan in the Acute Phase of Ischaemic Stroke, Archives of Medical Science (2011)
14. Evaluation of Quality of Life in Ischemic Stroke Patients Treated With Tissue Plasminogen Activator; [بررسی کیفیت زندگی بیماران سکته ی مغسی ایسکمیک درمان شده با فعال کننده ی پلاسمینوشن بافتی], Journal of Isfahan Medical School (2023)
15. Difference Between Risk Factors of Anterior and Posterior Circulation Strokes, Journal of Research in Medical Sciences (2007)
16. “Incidence, Characteristics and Prognosis of Cervical Artery Dissection-Induced Ischemic Stroke in Central Iran”, BMC Neurology (2022)
17. The Effect of Intravenous Tranexamic Acid on Preventing the Progress of Cerebral Hemorrhage in Patients With Brain Traumatic Injuries Compared to Placebo: A Randomized Clinical Trial, Medical Journal of the Islamic Republic of Iran (2020)
18. Predictors of Cerebral Venous Thrombosis and Arterial Ischemic Stroke in Young Asian Women, Journal of Stroke and Cerebrovascular Diseases (2012)
19. One-Year Survival and Prognostic Factors for Survival Among Stroke Patients: The Prove-Stroke Study, Journal of Research in Medical Sciences (2022)
20. Effect of Decompressive Hemicraniectomy on Mortality of Malignant Middle Cerebral Artery Infarction, Journal of Research in Medical Sciences (2010)
21. Epidemiologic Evaluation of Stroke Risk Factors Among Rural-Urban Patients in Isfahan University Hospitals, Iran, Journal of Isfahan Medical School (2012)
22. Comparison of Changes in Serum Fibrinogen Level in Primary Intracranial Hemorrhage (Ich) and Ischemic Stroke, ARYA Atherosclerosis (2012)
23. Half-Saline Versus Normal-Saline As Irrigation Solutions in Burr Hole Craniostomy to Treat Chronic Subdural Hematomata: A Randomized Clinical Trial, Korean Journal of Neurotrauma (2022)
24. Enoxaparin Initiation After Chronic Subdural Haematoma Evacuation: A Randomized Clinical Trial on Timing and Outcomes, Surgical Practice (2023)
25. Different Stroke Scales; Which Scale or Scales Should Be Used?, Caspian Journal of Internal Medicine (2021)
26. A Promising Method of Enhancement for Early Detection of Ischemic Stroke, Journal of Research in Medical Sciences (2012)
27. Temporal Trends of Stroke Incidence Over 14 Years in Iran: Findings of a Large-Scale Multi-Centric Hospital-Based Registry, Neurology Asia (2023)
28. Evaluation of Rivaroxaban Versus Warfarin for the Treatment of Cerebral Vein Thrombosis: A Case-Control Blinded Study, Current Journal of Neurology (2021)
29. Ischemic Stroke in Young Asian Women: Risk Factors, Subtypes and Outcome, Cerebrovascular Diseases (2010)
30. Asian Study of Cerebral Venous Thrombosis, Journal of Stroke and Cerebrovascular Diseases (2019)
31. Comparison of Acute Ischemic Stroke Evaluation and the Etiologic Subtypes Between University and Nonuniversity Hospitals in Isfahan, Iran, International Journal of Stroke (2019)
32. A Randomized Clinical Trial of Low-Dose Warfarin Therapy for Improving the Longevity of Permanent Arteriovenous Catheters, Annals of Vascular Surgery (2021)
33. Watershed Infarction in Covid-19: The Necessity of Neuroimaging in Patients With Subtle Neurological Symptoms, Current Journal of Neurology (2023)
34. The Correlation of Nitrate Concentration With Lesion Size in Initial Phase of Stroke; It Is Not Correlated With National Institute Health Stroke Scale, Journal of Research in Medical Sciences (2008)
35. Incidence of Neurological Syndromes After Thrombolytic Therapy in Elderly Patients With Acute Myocardial Infarction, Journal of Isfahan Medical School (2008)
36. The Effect of Statin Therapy in Stroke Outcome: A Double Blind Clinical Trial, International Journal of Preventive Medicine (2012)
37. Luxury Perfusion: A Paradoxical Finding and Pitfall of Ct Perfusion in Subacute Infarction of Brain, Radiology Case Reports (2019)
38. Epidemiologic Evaluation and Seasonal Variations of Stroke Risk Factors Among Patients With First and Recurrent Stroke, Journal of Isfahan Medical School (2012)